Genovis is launching a new enzyme product
Genovis is introducing a new enzyme that is being marketed under the name GingisKHAN™ for customers primarily in the pharmaceutical industry for characterization of antibody-based drugs.Genovis’ products are marketed under the name SmartEnzymes and are used in the biotech and pharmaceutical industries for characterization of biologics. Today, about 80% of all antibody-based drugs are based on IgG1 molecules, human immunoglobulin of subclass 1, which is also the most common antibody in the natural composition of human antibodies. GingisKHAN is an enzyme, cysteine protease, which splits IgG1